PMID: 9160380Apr 1, 1997Paper

Results of 12 years' combined maternal serum alpha-fetoprotein screening and ultrasound fetal monitoring for prenatal detection of fetal malformations in Havana City, Cuba

Prenatal Diagnosis
L RodríguezL Heredero

Abstract

Progressively since 1982 and as part of a nationwide programme for the diagnosis and prevention of genetic diseases, maternal serum alpha-fetoprotein (MS-AFP) screening and ultrasound fetal monitoring has been implemented in all pregnant women in Cuba. In Havana City, 328,983 pregnant women underwent MS-AFP screening between 15 and 19 weeks of gestational age. With a cut-off level of > or = 2 multiples of the normal median (MOM), 1767 amniocenteses were carried out to determine the levels of amniotic fluid AFP and 685 malformed fetuses were diagnosed. By ultrasound fetal monitoring, an additional 686 malformed fetuses were detected. As a result of the programme, the birth prevalence of neural tube defects has fallen by 90 per cent.

Citations

Nov 1, 2011·American Journal of Epidemiology·Allen J Wilcox, Donna D Baird
Jul 21, 1998·Annals of the New York Academy of Sciences·M I EvansG Critchfield
Nov 13, 2015·American Journal of Public Health·Callie A M AttaAmy Metcalfe
Aug 14, 2001·Clinics in Perinatology·M I EvansT H Bui

❮ Previous
Next ❯

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.